Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07211997 · ClinicalTrials.gov registry record

FebriDx® Pediatric Validation Study

A clinical trial of Acute Respiratory Infections (ARIs), sponsored by Lumos Diagnostics.

Recruiting
Registry status
800
Enrollment target
10
Study locations

NCT07211997 is a study of Acute Respiratory Infections (ARIs) that is actively recruiting participants, run by Lumos Diagnostics. The registered enrollment target is 800 participants, above the 97-participant average among 3 other Acute Respiratory Infections (ARIs) trials with a reported enrollment target (725% higher). The trial reports 10 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07211997, a study of Acute Respiratory Infections (ARIs), is actively recruiting participants, sponsored by Lumos Diagnostics.

RECRUITING
Registry status
800 participants
Enrollment target
10
Study locations

Study Summary

The primary objective of this study is to determine performance characteristics of the FebriDx® test in differentiating bacterial from non-bacterial etiology among febrile pediatric patients (2-11 years) presenting to the emergency department, urgent care center or primary care office with a suspected acute respiratory tract infection.

Interventions

  • DEVICE FebriDx

Study Locations (10)

Florida

  • PAS Research- Myrtle Avenue Pediatrics, Inc - Clearwater
  • PAS Research- Sandhill Pediatrics PA - Lutz
  • PAS Research - Tampa

Ohio

  • Hometown Urgent Care - Huber Heights
  • Hometown Urgent Care - Springfield

South Carolina

  • Tribe - Charleston
  • Tribe- Parkside Pediatrics - Greenville

California

  • Avacare - Colton

Pennsylvania

  • PAS Research - Pittsburgh

Texas

  • PAS Research - Edinburg

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2025-10-09
Est. Completion 2026-11-30

Sponsor

Lumos Diagnostics

6 total trials

What the Registry Record Tells You About NCT07211997

The ClinicalTrials.gov registry entry for NCT07211997 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 97-participant average among 3 other Acute Respiratory Infections (ARIs) trials with a reported enrollment target (725% higher). The listed sponsor is Lumos Diagnostics, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Respiratory Infections (ARIs) appearing as the primary indexed condition, and to 1 intervention - of which FebriDx is the first listed.

NCT07211997 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Florida, Ohio, South Carolina.

Frequently Asked Questions

What is clinical trial NCT07211997 about?

NCT07211997 is a clinical study titled "FebriDx® Pediatric Validation Study". The primary objective of this study is to determine performance characteristics of the FebriDx® test in differentiating bacterial from non-bacterial etiology among febrile pediatric patients (2-11 years) presenting to the emergency department, urgent care center or primary care office with a suspect...

What is the current status of trial NCT07211997?

This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2025-10-09. Estimated completion is 2026-11-30.

What conditions does trial NCT07211997 study?

This clinical trial studies the following conditions: Acute Respiratory Infections (ARIs).

What interventions are being tested in trial NCT07211997?

The interventions under investigation include: FebriDx (DEVICE).

Who is sponsoring clinical trial NCT07211997?

This trial is sponsored by Lumos Diagnostics, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07211997 being conducted?

This trial has 10 study locations across California, Florida, Ohio, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Respiratory Infections (ARIs)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.